New research out of WSU confirms something a lot of us probably suspected: we have no idea what we're doing when it comes to cannabis and breastfeeding. The study, led by Dean Courtney Meehan, found that infants breastfed by mothers who smoke or vape cannabis show volatile organic compounds (VOCs) in their urine. The levels spike after the mom uses. This is the first study to look at this specific exposure pathway, and the honest answer from the researchers is "we don't know yet" if those concentrations are high enough to hurt the baby. That is not a satisfying answer, but it is the only honest one. It also connects to another recent WSU study about how people react when they think AI is coming for their job, If you think AI is coming for your job, you might start slacking off. In both cases, people are making decisions based on incomplete information, and the research is trying to catch up to behavior that is already normalized.
Our take is simple: pass the bong, not the breastmilk, until we know more. Meehan's team surveyed women a couple of years ago and found that many new moms use cannabis because they view it as safer than pharmaceutical alternatives. That is a reasonable instinct, given what we know about opioids and other prescription drugs. But "safer than the alternative" is not the same as "safe." The study does not prove that these VOCs cause harm. It proves that they are there, and that they increase after the mom uses. That is enough to warrant caution. It is also enough to make you wonder why we are not funding this research faster. Cannabis acceptance is outpacing the science, and that gap is where bad decisions get made. Meanwhile, Keith Brown deleted his social media to lock in on WSU's defense, Keith Brown deleted social media to lock in on WSU's defense, and there is something to that approach. When the information is not clear, sometimes you tune out the noise and focus on what you can control. For a breastfeeding mom, that means asking her doctor a question the doctor probably cannot answer yet.
What makes this study so frustrating is that it raises a question without answering it. Meehan is direct about this: "We do not know whether the concentrations of VOCs found in our study are high enough to impact infant health." That is not a hedge. That is a confession of ignorance, and it is the most important sentence in the entire paper. The CDC analyzed the samples. The science is solid. But the sample size is small, the mechanism is unclear, and the long-term outcomes are a complete blank. That is where we are. Meehan wants doctors to have this information so they can inform their patients, and she wants patients to have it so they can make data-informed decisions. The problem is that the data is not finished yet. She is asking for more research, and she is right to do so.
Here is the concrete takeaway: if you are a nursing mom in Washington or Oregon who uses cannabis, you are making a decision without a road map. This study gives you one signpost, VOCs show up in your baby's urine after you use, but it does not tell you how fast to stop or how far is far enough. Watch for the follow-up study. If those VOC levels correlate with measurable health outcomes, the conversation changes from "we don't know" to "we should have known sooner." Until then, the safest move is the one that requires the least guesswork. Go Cougs.